Abstract. Gastric cancer continues to be a major threat to human health. Molecular descriptions on the diverse phases of this disease will be valuable for a better diagnosis and development of therapeutic targets. Previously, a 92-gene classifier that distinguishes tumor from non-tumor gastric tissues was proposed. To corroborate this finding, independent approaches of gene selection and class prediction algorithm were applied to the dataset of 86 tissues profiled on 17K cDNA microarrays. As a result, 22 genes were selected, of which 18 were in common with 92 genes previously shown. The differential expression patterns of Chromogranin A (CHGA) and Thy-1 cell surface antigen (THY1) were further validated with immunohisto-staining on gastric tissue microarrays. The differential expression patterns of several of the proposed genes have been proven to be critical for tumor progression in other cancer models and will likely function as novel biomarkers for gastric cancer as well.
Introduction
Gastric cancer is a major cause of human cancer-related death and certain risk factors affecting the development of gastric cancer, including age, gender, race, diet, Helicobacter pylori infection and clinicopathological parameters are well characterized (1) (2) (3) . However, the molecular mechanisms underlying this specific cancer are still not clear. Even though ongoing cancer drug trials have shown signs of benefits (4) , identification of molecular markers in the diverse phases of gastric cancer will continuously be needed to supplement the mostly histopathology-based diagnosis and for the development of therapeutic tools.
Recent advancements in genomics, epigenomics and proteomics-based high throughput screening technologies are being actively applied to the dissection of gastric cancer to elucidate the molecular nature of the disease (5) (6) (7) (8) . A recent report on the gene expression profiling of 86 gastric tissues on 17K cDNA microarray led to the identification of 92 genes that showed a significant difference in expression levels between non-tumorous and tumor tissues (9) . In the current study, in order to narrow down the list and corroborate the previous results, independent gene selection and class prediction algorithm were employed to select for the 22-gene classifier. Immunostaining of two of the genes, CHGA and THY1, on tissue microarrays confirms the relative expression level of the selected genes at the protein level.
Materials and methods
Tissue samples, RNA extraction and cDNA microarray hybridization. Tissue samples, RNA extraction and hybridization on 17K cDNA microarrays were detailed in a recent publication (9) . Tissues used for the profiling experiments are composed of 29 pairs (29 normal tissues and 29 matching tumor tissues, n=58) and a test set of 28 samples (7 pairs, 8 non-paired normal tissues and 6 non-paired 72 tumor tissues). The microarray hybridizations were performed in a reference RNA-based indirect-design, in which each of the cDNA targets generated from tissue total RNAs (Cy5-labeled) was competitively hybridized with common reference RNA-generated cDNAs labeled with Cy3. Hybridized slides were scanned with a Gene Pix 4000B laser scanner (Axon Instrument Inc, Union City, CA) and the raw data were saved in a Gene Pix Result (GPR) format.
Microarray data analysis. To exclude any possible bias due to the use of the k-nearest neighbor-based class prediction method used before, a different approach in class prediction implemented in the BRB ArrayTools developed by Dr Richard Simon and Amy Peng Lam was tested. The 17K cDNA microarray contains 15,723 gene probes. All the GPRs were imported into the BRB ArrayTools bioinformatics program. Probes with fluorescent intensities <100 in the Cy3 and Cy5 channels, or those containing a flag signal were removed. Probes with a spot diameter <10 or any missing values were also removed from further analysis in the filtering step. Print tip, lowess normalization was applied to the entire dataset to adjust dye-dependent bias. Following the filtering step, 10,012 genes were left to be used for the analysis. In the class prediction function of BRB ArrayTools, gene selection was performed using a 'greedy pairs method' (10), which identifies pairs of genes that separates two classes (in this case, tumor and non-tumor), to select 11 pairs of genes. The prediction error (misclassification) rate in the training set was estimated by leave-one-out crossvalidation.
Four different class prediction methods of the linear discriminant analysis, the 1-nearest neighbor, the 3-nearest neighbors and the nearest centroid were individually tested (refer to the BRB ArrayTool manual for descriptions and references for each of the methods). A statistical test of cross-validated misclassification rate was performed by 100 permutations. For each predictor, this test estimates a p-value for the global test of the hypothesis that the predictor is picking up the random noise in the data whereas classes do not differ at all with regard to expression profiles. A permutation analysis is used for the computation of the p-value for the global test. Class labels of the samples are randomly permuted 100 times. For each permutation, samples are classified and the cross-validated misclassification rate of each classifier is computed as a proportion of correctly predicted samples. The p-value of the predictor is the proportion of permutations with a misclassification rate smaller than the misclassification rate of the original labeling.
Based on 100 random permutations, classifiers (11 pairs or 22 genes) from each of the 4 prediction methods had a p-value of <0.01. Table I . Sensitivity and specificity of the 22-gene classifier. 
PPV (positive predictive value) is the probability that a sample predicted as class A actually belongs to class A. NPV (negative predictive value) is the probability that a sample predicted as non class A actually does not belong to class A.
- Immunohistochemical staining on tissue microarrays. Mouse monoclonal antibodies against CHGA (1:500) (Dako, Denmark) and THY1 (Abcam Inc., Cambridge, MA) were used to validate the differential expression levels of these two genes at the protein level by immunostaining on tissue microarrays with provided protocol (Super Bio Chips, Seoul, Korea).
Results
Selection of the 11-pair class predictors. Twenty-two genes were selected that were differentially expressed between the gastric adenocarcinomas and adjacent, histologically normal gastric tissues. In the two-way (sample and genes) hierarchical clustering of the 58 tissues in the training set, the genes were clearly able to distinguish the two tissue types (Fig. 1) . The 22-gene classifiers showed 100% efficiency in cross-validation in the training set and are highly sensitive (class A sample to be correctly predicted as class A) and specific (non class A sample to be correctly predicted as non-A) (Table I) . These classifiers can also correctly predict the tissue types in the test set (Table II) as a group. Some of the selected genes are components of important biological pathways; Ghrelin/obestatin preprohormone (GHRL) and Somatostatin (SST) are members of the neuroactive ligandreceptor interaction pathway. Inhibin, ß A (INHBA) is a member of TGF-ß signaling pathway, whereas THY1 and INHBA are members of leukocyte transendothelial migration and cytokine-cytokine receptor interaction pathways, respectively.
Validation of differential gene expression by immunohistochemical staining on tissue microarrays.
The relative expression ratios of 22 genes are shown in Fig. 2 and are detailed in Table III . The differential expression of two genes was further confirmed by immunostaining. CHGA shows about a 30-fold relative increase in gene expression ratios in normal gastric tissues. In the immunohistochemical staining on tissue microarrays with CHGA antibody, the overexpression in the normal tissue is confirmed (Fig. 3) . CHGA shows high expression in each of the 59 normal gastric tissues, whereas it shows only weak expression in 5 tissues and relatively high expression in 2 of the tissues (data not shown). THY1 was barely observable in non-tumor tissues, whereas it shows both cytoplasmic and nuclear staining in most of the tumor tissues (data not shown).
Discussion
The purpose of this study was to identify a smaller number of genes that can be used as model genes in a biochemical study of gastric cancer at the molecular level. Additionally, these genes may become assets in the development of molecular probes in the diagnosis of gastric cancer. What is different from an earlier study was that independent gene selection and class prediction algorithms were employed in order to minimize statistical bias. The gene selection in this study is based on the selection of differentially expressed between the classes at a univariate parametric significance level of p<0.001. In a comparison with the 92 genes previously identified (9), 18 of the 22 genes are selected in common, the 4 different genes being Actin-like 6A (ACTL6A), WD repeats 
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and SOF1 domain containing (WDSOF1), Midnolin (MIDN) and V-set and immunoglobulin domain containing 2 (VSIG2). Of the 22 genes, the gene products of Glutathione peroxidase 3 (plasma) (GPX3), INHBA, Lipase, gastric (LIPF) and CHGA are soluble proteins that deserve to be studied more for diagnosis purposes. The expression patterns of the selected genes coincide well with those reported in other publications. For example, GPX3, a secretory protein with an antioxidant activity, shows an average of a 3.6-fold increase in expression level in normal gastric tissues compared to gastric adenocarcinoma in the current analysis (Table III) . In Barrett's adenocarcinomas (BAs), consistently reduced levels of GPX3 mRNA and protein in tumor samples were observed and the decreased gene expression in the tumor was due to hypermethylation in the promoter region of GPX3 (11) . Similar results have been observed in prostate cancer, where GPX3 is hypermethylated and inactivated during prostate cancer progression (12) . Furthermore, in a search for cancerspecific CpG methylation that may serve as a tumor marker, Lodygin et al found that GPX3 showed the highest frequency of promoter CpG methylation in primary prostate cancer samples (13) . INHBA and INHA (α subunit of Inhibin), form a pituitary follicle-stimulating hormone (FSH) secretion inhibitor and have a tumor-suppressor activity. The expression level of INHBA is significantly overexpressed in mouse models of Wnt-induced tumors (14) and, likewise, its expression in gastric adenocacinoma is 10-fold higher than in normal gastric tissues (Table III) . CHGA is a molecular marker for tumors expressing neuroendocrine (NE) cell differentiation. It was reported as being overexpressed in small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC) tumors and cell lines (15) and immunohistostaining confirms its overexpression in gastric cancer (Fig. 2) . Estrogen-related receptor γ (ESRRG), overexpressed ~25-fold in normal gastric tissues (Table III) , was also reported as being expressed in normal human prostatic epithelial cells, though its expression decreased with the prostate cancer cells and tissues (16, 17 
